
0:00
NaN:NaN:NaN
A case in which the Court held that generic drug makers cannot be sued for not warning about potentially dangerous side effects on their drug labels, even when they follow federal rules that only require their labels to match those of their brand-name equivalents.
D'autres épisodes de "U.S. Supreme Court 2010 Term Arguments"



Ne ratez aucun épisode de “U.S. Supreme Court 2010 Term Arguments” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.








